All Abstracts are published in The Netherlands Journal of Medicine (1999) Vol 54 Supplement Page Number at end of each Reference
PU01: The practical application and interpretation of flow volume curves
in CF.
Paul L.P. Brand. S15
PU02: Value of more comprehensive lung function tests in children.
C.K. van der Ent. S15
PU03: Lung function measurements in infants and toddlers with cystic
fibrosis (CF): clinical and physiological relevance.
U. Frey.
S15-S16
PU04: Lung inflammation and airway structure and function.
H.A.W.M. Tiddens, L.P. Koopman, RX. Lambert, T.W. van der Mark, W.J. de
Boer, I.C. de Jongste. S17
PU05: Monitoring of pulmonary exacerbations in CF patients with
conventional and alternative lung function tests.
H.G.M. Arets, J. Van
der Laag, CK van der Ent S49
PU06: Comparison of capillary C02 (PcC02) with end-tidal C02 (PeC02) in
patients with cystic fibrosis (CF).
A. Serra, G. Polese, U. Pradal, A.
Rossi, C. Braggion, G. Mastella S49-S50
PU07: Exhaled carbon monoxide level at rest and during exercise in
cystic fibrosis.
P. Apor, I.Horvath, P. Borka. S50
PU08: Diagnostic value of recombinant aspergillus furnigatus antigens
(rAsp.L) in patients with CF.
Carmen Casaulta Acbischer, Stefanic
Hemmann, Reto Cramen, Kurt Blaser, Martin H. Schöni S50
PU09: Aspergillosis and cystic fibrosis: results of national
retrospective investigation.
A. Baculard, A. Munck, G. Rault, M.
Roussey, G. Tournier S50
PU10: The value of rint when assessing the response to bronchodilator
treatment in children with cystic fibrosis.
L. Morrison, J. Langley,
S.P. Conway, K.G. Brownlee, R. Ball. S50-S51
PU11: The value of monitoring rint in children with cystic fibrosis over
a course of intravenous antibiotic treatment.
L. Morrison, J. Langley,
S.P. Conway, K.G. Brownlee, R. Ball S51
PU12: The prognostic value of FVC and FEV1/FVC in the CF children.
I.Popa, L. Pop, Z. Popa , C.Bunu S51
PU13: Passive smoking and lung function in children with cystic
fibrosis: a live year study.
A. Smyth, U. O'Hea , R.L. Smyth
S51
PU14: Comparison of lung volumes measured by different methods in adult
patients with cystic fibrosis.
E. Amelina, A. Chemiak, A. Chuchalin.
S51-S52
PU15: Evaluation of pulmonary abnormalities in adult patients with
cystic fibrosis through the comparison of HRCT with pulmonary function tests.
M. Wierzbicka, W. Skorupa, J. Kus, M. Franczuk, J. Kowalski, I. Bestry,
L. Pawlicka S52
PU16: RHDNASE 1 therapy in CF patients with normal lung function: are
(HRCT) high resolution computer tomography chest scan results predictive for
efficacy?
B. Roos-Liegmann, H. Schmidt, B. Krackhardt, P. Leitzmann, J.
Bargon, H.G. Posselt S52
PU17: The value of routine chest x-rays when starting intravenous
antibiotic treatment for respiratory exacerabations.
H.Beresford, S.P.
Conway, R. Robertson, C. Etherington, A. Watson, K. Pollard, D. Peckham, P.
Pearson S52-S53
PU18: Echocardiography in adult patients with cystic fibrosis.
G.
Nekludova, C. Naumenko. E. Amelina, A. Chemiaev. S53
PU19: Bronchial artery embolization in CF: a clinical point of view.
F. Pardo, M. Collura, M.L. Furnari, L. Termini, D.Messana, S. Salerno
S53
PU20: Long term results of lobar resection for focal bronchlectasis.
G.J. Connett, J. Maddison, J. Fairhurst S53
PU21: Prevalence of urinary incontinence (UI) in women with cystic
fibrosis (CF).
M. Cornacchia, A. Zenorini, C. Braagion, S. Perobelli,
L.M. Cappelletti, G. Mastella. S53-S54
PU22: Respiratory allergy in patients with cystic fibrosis.
V.
Lucidi, T. Salerno, S. Mancini, S. Bella, R Rosati, A. Diamanti, M. Castro.
S54
PU23: Noninvasive positive pressure ventilation in cystic fibrosis: A
report of 11 children.
A. Caheree, K. Dieckmann, C. Talbotec, S.
Marchand, C. Maurage, C. Giraut, J.C. Rolland. S54
PU24: Follow up of allergic bronchopulmonary aspergillosis (ABPA) in
patients with CF.
S. Junge, H. von der Hardt. S54
PU25: Genetic factors and association of CF and ABPA.
M. Skov,
LP. Pandey, P. Garred, N. Høiby, C. Koch. S54-S55
PU26: Influence of chest physiotherapy by bouncing on gastro-oesophageal
reflux (GOR) in infants.
F. Van Ginderdeuren, A. Malfroot, L.
Opdeweegh, G. Godier, V. Vandeuplas, I. Dab S55
PU27: Occurance of and motivation for chest physiotherapy at Stockholm
CF-center. Contact-stimulating physiotherapy in infants with CF (birth to 2
years).
L. Smoliková D. Zemková, V Vávrová.
S55
PU28: Comparison of flutter VRPI and forced expirations (FE) with active
cycle of breathing techniques (ACBT) in subjects with cystic fibrosis (CF).
S.E. Pike, A.C. Machin, K.J. Dix, LA. Pryor, M.E. Hodson.
S55-S56
PU29: Comparative study of efficiencies of select physiotherapy methods
used in the treatment of cystic fibrosis.
T. Orlik, R. Piotrowski, D.
Sands. S56
PU30: Repeatability of the 10 meter shuttle walk test in children with
cystic fibrosis.
D. Rogers, I.J.M. Doull. S56
PU31: Repeatability of a self reported exercise questionnaire in stable
paediatric cystic fibrosis patients.
D. Rogers, I.J.M. Doull.
S56
PU32: The effect of a winter camp for cystic fibrosis patients at the
dead sea region.
E.M. Berkovits, E. Sabo, A. Tal
S56-S57